Methods of inhibiting cancer metastasis using polypeptides targeting chemokine receptors April 28, 2003
NIH licensing opportunity: methods of inhibiting amino acid formation and tumor angiogenesis April 25, 2003
Tyrosine kinase inhibitors and their use in cancer, angiogenesis, etc., claimed by Allergan April 25, 2003